Cutaneous hyalohyphomycosis caused by Purpureocillium lilacinum in an immunocompetent patient: case report and review

References

• de Hoog GS, Guarro J, Gene J, Figueras MJ. Atlas of Clinical Fungi, 2nd edn. Baarn, The Netherlands: Centraalbureau Voor Schimmelcultures, 2000: 794–809.
   Google Scholar
• Luangsa-Ard J, Houbraken J, van Doorn T, et al. Purpureocillium, a new genus for the medically important Paecilomyces lilacinus. FEMS Microbiol Lett 2011; 321: 141–149.
   PubMed Web of Science ®Google Scholar
• Hocquette A, Grondin M, Bertout S, Mallié M. Acremonium, Beauveria, Chrysosporium, Fusarium, Onychocola, Paecilomyces, Penicillium, Scedosporium and Scopulariopsis fungi responsible for hyalohyphomycosis. J Mycol Med 2005; 15: 136–149 [in French].
   Web of Science ®Google Scholar
• Pastor FJ, Guarro J. Clinical manifestations, treatment and outcome of Paecilomyces ilacinus infections. Clin Microbiol Infect 2006; 12: 948–960.
   PubMed Web of Science ®Google Scholar
• Van Schooneveld T, Freifeld A, Lesiak B, et al. Paecilomyces lilacinus infection in a liver transplant patient: case report and review of the literature. Transpl Infect Dis 2008; 10: 117–122.
   PubMed Web of Science ®Google Scholar
• Chan-Tack KM, Thio CL, Miller NS, et al. Paecilomyces lilacinus fungemia in an adult bone marrow transplant recipient. Med Mycol 1999; 37: 57–60.
   PubMed Web of Science ®Google Scholar
• Clark NM. Paecilomyces lilacinus infection in a heart transplant recipient and successful treatment with terbinafine. Clin Infect Dis 1999; 28: 1169–1170.
   PubMed Web of Science ®Google Scholar
• Aguilar C, Pujol I, Sala J, Guarro J. Antifungal susceptibilities of Paecilomyces species. Antimicrob Agents Chemother 1998; 42: 1601–1604.
   PubMed Web of Science ®Google Scholar
• Castelli MV, Alastruey-Izquierdo A, Cuesta I, et al. Susceptibility testing and molecular classification of Paecilomyces spp. Antimicrob Agents Chemother 2008; 52: 2926–2928.
   PubMed Web of Science ®Google Scholar
• Gutierrez-Rodero F, Moragon M, Ortiz de la Tabla V, Mayol MJ, Martin C. Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus in an immunocompetent host successfully treated with itraconazole: case report and review. Eur J Clin Microbiol Infect Dis 1999; 18: 814–818.
   PubMed Web of Science ®Google Scholar
• Cassagne C, Ranque S, Normand AC, et al. Mould routine identification in the clinical laboratory by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. PLoS One 2011; 6: e28425.
   Web of Science ®Google Scholar
• Takayasu S, Akagi M, Shimizu Y. Cutaneous mycosis caused by Paecilomyces lilacinus. Arch Dermatol 1977; 113: 1687–1690.
   PubMedGoogle Scholar
• Hall VC, Goyal S, Davis MDP, Walsh JS. Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus: report of three cases and review of the literature. Int J Dermatol 2004; 43: 648–653.
   PubMed Web of Science ®Google Scholar
• Hecker MS, Weinberg JM, Bagheri B, et al. Cutaneous Paecilomyces lilacinus infection: report of two novel cases. J Am Acad Dermatol 1997; 37: 270–271.
   PubMed Web of Science ®Google Scholar
• Gottlieb T, Atkins BL. Successful treatment of cutaneous Paecilomyces lilacinus infection with oral itraconazole in an immune competent host. Mycoses 2001; 44: 513–515.
   PubMed Web of Science ®Google Scholar
• Zendri E, Martignoni G, Benecchi M, Fanti F, De Panfilis G. Paecilomyces lilacinus cutaneous infection associated with a dog bite. J Am Acad Dermatol 2006; 55: 63–64.
   Web of Science ®Google Scholar
• Cho GY, Choo EH, Choi GJ, Hong NS, Houh W. Facial cutaneous mycosis by Paecilomyces lilacinus. Korean J Dermatol 1984; 22: 89–93.
   Google Scholar
• Bassiri Jahromi S, KhaksarIran AA. Cutaneous hyalohyphomycosis in a woman with normal immune system. Iran J Med Sci 2007; 32: 51–53.
   Google Scholar
• Liu K, Howell DN, Perfect JR, Schell WA. Morphologic criteria for the preliminary identification of Fusarium, Paecilomyces, and Acremonium species by histopathology. Am J Clin Pathol 1998; 109: 45–54.
   PubMed Web of Science ®Google Scholar
• Castelli MV, Alastruey-Izquierdo A, Cuesta I, et al. Susceptibility testing and molecular classification of Paecilomyces spp. Antimicrob Agents Chemother 2008; 52: 2926–2928.
   PubMed Web of Science ®Google Scholar
• Chandenier J, Ledu S, Machet MC, et al. Management of Paecilomyces lilacinus paecilomycosis: contribution of susceptibility testing, cure by surgery and voriconazole. J Mycol Med 2004; 14: 134–136 [in French].
   Web of Science ®Google Scholar
• Hilmarsdottir I, Thorsteinsson SB, Asmundsson P, Bodvarsson M, Arnadottir M. Cutaneous infection caused by Paecilomyces lilacinus in a renal transplant patient: treatment with voriconazole. Scand J Infect Dis 2000; 32: 331–332.
   PubMedGoogle Scholar